During the past decade, University of Zimbabwe Clinical Research Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Zimbabwe Clinical Research Centre" #1 sponsor was "Kirby Institute" with 3 trials, followed by "Anna Griffiths, MRC" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Hospital Universitario 12 de Octubre" with 1 trials sponsored and "Justine Boles" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Zimbabwe Clinical Research Centre" #1 collaborator was "PENTA Foundation" with 2 trials as a collaborator, "UNITAID" with 2 trials as a collaborator, "University of Zimbabwe" with 2 trials as a collaborator, "ViiV Healthcare" with 2 trials as a collaborator and "AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of Zimbabwe Clinical Research Centre" are "HIV Infections" (4 trials), "HIV" (2 trials), "Human Immunodeficiency Virus" (2 trials), "Acquired Immune Deficiency Syndrome (AIDS)" (1 trials) and "Contraception" (1 trials). Many other conditions were trialed in "University of Zimbabwe Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "University of Zimbabwe Clinical Research Centre" are "Drug" (7 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "3TC 300 MG Oral Tablet" (1 trials), "ATV" (1 trials), "Albendazole" (1 trials), "Aluvia + 2NRTIs" (1 trials) and "Aluvia + raltegravir" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Zimbabwe Clinical Research Centre" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Zimbabwe Clinical Research Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Zimbabwe Clinical Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Zimbabwe Clinical Research Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".